| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, HARBOR GENERAL HOSPITAL CAMPUS OF THE UCLA SCHOOL OF MEDICINE TORRANCE, CALIFORNIA 90509
hLH
, WHOSE PRIMARY AMINO ACID SEQUENCE IS KNOWN, WAS REDUCED AND S-CARBOXYMETHYLATED (RCM) TO REMOVE SECONDARY AND TERTIARY STRUCTURE. RCM-hLH
WAS UTILIZED FOR DEVELOPMENT OF A "SEQUENCE SPECIFIC" RIA. RCM-hLH
RIA REVEALED THAT THE NH2-TERMINAL TRYPTIC PEPTIDE OF hLH
(CONSISTING OF ONLY 32 AMINO ACID RESIDUES) WAS NEARLY AS IMMUNOREACTIVE AS THE ENTIRE RCM-hLH
MOLECULE (CONSISTING OF 89 RESIDUES). NO OTHER TRYPTIC PEPTIDE WAS IMMUNOACTIVE. REDUCED AND S-CARBAMIDOMETHYLATED hLH
, DIFFERING ONLY SLIGHTLY IN STRUCTURE FROM RCM-hLH
, WAS WEAKLY ACTIVE IN THE RCM-hLH
RIA, DEMONSTRATING THE UTILITY OF THIS RIA FOR PRECISE STUDY OF STRUCTURE-IMMUNOLOGIC ACTIVITY RELATIONSHIPS.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |